<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Generative Artificial Intelligence in Bioinformatics: A Systematic Review of Models, Applications, and Methodological Advances - Health AI Hub</title>
    <meta name="description" content="This systematic review comprehensively analyzes the transformative impact of Generative Artificial Intelligence (GenAI) across various bioinformatics subfields,">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Generative Artificial Intelligence in Bioinformatics: A Systematic Review of Models, Applications, and Methodological Advances</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.03354v1" target="_blank">2511.03354v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-05
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Riasad Alvi, Sayeem Been Zaman, Wasimul Karim, Arefin Ittesafun Abian, Mohaimenul Azam Khan Raiaan, Saddam Mukta, Md Rafi Ur Rashid, Md Rafiqul Islam, Yakub Sebastian, Sami Azam
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CL, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.03354v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.03354v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This systematic review comprehensively analyzes the transformative impact of Generative Artificial Intelligence (GenAI) across various bioinformatics subfields, including genomics, proteomics, structural biology, and drug discovery. It evaluates GenAI models, applications, and methodological advances through six research questions, highlighting their superior performance over traditional methods, benefits of specialized architectures, and current limitations while proposing future research directions.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>GenAI's breakthroughs in genomics, proteomics, structural biology, and drug discovery directly accelerate medical research by enabling more accurate disease understanding, novel therapeutic target identification, and efficient development of diagnostics and personalized treatments, ultimately improving patient care.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>Generative AI is applied to enhance drug discovery processes, accelerate molecular design, improve structural modeling and functional prediction of biomolecules, and provide advanced analysis and integration of complex biological and medical data (genomic, proteomic, cellular, and genetic disorder information) for better understanding disease and developing therapies.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>A systematic review framework, utilizing six specific research questions (RQs) and PRISMA methods, was employed to evaluate GenAI's role in bioinformatics.</li>
                    
                    <li>GenAI models demonstrate superior predictive performance and output generation in diverse applications such as sequence analysis, molecular design, and integrative data modeling compared to traditional methods.</li>
                    
                    <li>Specialized GenAI model architectures, leveraging targeted pretraining and context-aware strategies, consistently outperform general-purpose models.</li>
                    
                    <li>Significant benefits are observed in molecular analysis and data integration, leading to improved accuracy, reduced errors, and advancements in structural modeling and functional prediction.</li>
                    
                    <li>The primary applications span genomics, proteomics, transcriptomics, structural biology, and drug discovery, facilitating data-intensive discovery and integrative biological analysis.</li>
                    
                    <li>Key constraints include scalability issues and data biases, which negatively impact the generalizability of GenAI models.</li>
                    
                    <li>Training and generalization of these models are broadly supported by molecular (e.g., UniProtKB, ProteinNet12), cellular (e.g., CELLxGENE, GTEx), and textual (e.g., PubMedQA, OMIM) biological datasets.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>A systematic review was conducted based on six predefined research questions (RQs), adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methods. The objective was to systematically identify and evaluate GenAI strategies, models, applications, and methodological advances in bioinformatics, focusing on predictive performance, specialization, and impact across various subfields.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>GenAI models demonstrate superior performance in diverse bioinformatics tasks, including sequence analysis, molecular design, and integrative data modeling, significantly outperforming traditional methods. Specialized model architectures, due to targeted pretraining, prove more effective than general-purpose models. These advancements lead to improved accuracy and reduced errors in complex molecular analysis, structural modeling, functional prediction, and synthetic data generation, validated by established benchmarks.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The enhanced accuracy in molecular analysis, structural modeling, and functional prediction offers significant potential for more precise disease diagnosis, deeper understanding of disease mechanisms, and accelerated development of novel drug candidates. This facilitates the implementation of targeted therapies and personalized medicine strategies, potentially leading to improved treatment efficacy and reduced adverse events in clinical settings.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The primary constraints identified include a lack of scalability in current GenAI models, hindering their application to extremely large or complex biological systems, and inherent biases within the training data, which can negatively impact the generalizability and robustness of models across diverse biological and patient populations.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Future research should prioritize the development of more robust evaluation methodologies for GenAI models to ensure their reliability and validity. Furthermore, integrating biologically grounded modeling approaches is crucial to enhance model generalizability and ensure their relevance and applicability in clinical and translational settings.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Genetics</span>
                    
                    <span class="tag">Infectious Diseases</span>
                    
                    <span class="tag">Personalized Medicine</span>
                    
                    <span class="tag">Diagnostics</span>
                    
                    <span class="tag">Structural Biology</span>
                    
                    <span class="tag">Molecular Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Generative AI</span>
                    
                    <span class="tag tag-keyword">Bioinformatics</span>
                    
                    <span class="tag tag-keyword">Genomics</span>
                    
                    <span class="tag tag-keyword">Proteomics</span>
                    
                    <span class="tag tag-keyword">Drug Discovery</span>
                    
                    <span class="tag tag-keyword">Structural Biology</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                    <span class="tag tag-keyword">Systematic Review</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Generative artificial intelligence (GenAI) has become a transformative
approach in bioinformatics that often enables advancements in genomics,
proteomics, transcriptomics, structural biology, and drug discovery. To
systematically identify and evaluate these growing developments, this review
proposed six research questions (RQs), according to the preferred reporting
items for systematic reviews and meta-analysis methods. The objective is to
evaluate impactful GenAI strategies in methodological advancement, predictive
performance, and specialization, and to identify promising approaches for
advanced modeling, data-intensive discovery, and integrative biological
analysis. RQ1 highlights diverse applications across multiple bioinformatics
subfields (sequence analysis, molecular design, and integrative data modeling),
which demonstrate superior performance over traditional methods through pattern
recognition and output generation. RQ2 reveals that adapted specialized model
architectures outperformed general-purpose models, an advantage attributed to
targeted pretraining and context-aware strategies. RQ3 identifies significant
benefits in the bioinformatics domains, focusing on molecular analysis and data
integration, which improves accuracy and reduces errors in complex analysis.
RQ4 indicates improvements in structural modeling, functional prediction, and
synthetic data generation, validated by established benchmarks. RQ5 suggests
the main constraints, such as the lack of scalability and biases in data that
impact generalizability, and proposes future directions focused on robust
evaluation and biologically grounded modeling. RQ6 examines that molecular
datasets (such as UniProtKB and ProteinNet12), cellular datasets (such as
CELLxGENE and GTEx) and textual resources (such as PubMedQA and OMIM) broadly
support the training and generalization of GenAI models.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>